HAGEMAN G J,STIERUM R H.Niacin,poly(ADP-ribose) polymerase-1 and genomic stability[J].Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis,2001,475(1/2):45-56.
REAL D E,NELSSEN J L,UNRUH J A,et al.Effects of increasing dietary niacin on growth performance and meat quality in finishing pigs reared in two different environments[J].Journal of Animal Science,2002,80(12):3203-3210.
CARLSON L A,OR？ L.The effect of nicotinic acid on the plasma free fatty acids demonstration of a metabolic type of sympathicolysis[J].Acta Medica Scandinavica,1962,172(6):641-645.
[11]
SZAPARY P O,RADER D J.Pharmacological management of high triglycerides and low high-density lipoproetin cholesterol[J].Current Opinion in Pharmacology,2001,1(2):113-120.
[12]
GYLLING H,MIETTINEN T A.Combination therapy with statins[J].Current Opinion in Investigational Drugs,2002,3:1318-1323.
[13]
KNOPP R H.Drug treatment of lipid disorders[J].The New England Journal of Medicine,1999,341:498-511.
[14]
OLSSON A G.Nicotinic acid and derivatives[M]//SCHETTLER G,HABENICHT A J R.Principles and Treatment of Lipoprotein Disorders.Handbook of experimental pharmacology.Berlin Heidelberg:Springer,1994,349-400.
